Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11583504 Stabilized formulations of lipid nanoparticles
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
November 8, 2017
Date of Patent
February 21, 2023
Patent Application Number
16348335
Patent Citations
US Patent 10392341 Compounds and compositions for intracellular delivery of therapeutic agents
US Patent 10442756 Compounds and compositions for intracellular delivery of therapeutic agents
US Patent 10799463 Compounds and compositions for intracellular delivery of agents
US Patent 11203569 Crystal forms of amino lipids
US Patent 11066355 Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
US Patent 11220476 Compounds and compositions for intracellular delivery of therapeutic agents
US Patent 10106490 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
US Patent 10166298 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
Patent Citations Received
US Patent 12129223 Lipids for use in lipid nanoparticle formulations
0
US Patent 11969506 Lipid nanoparticle formulation
0
US Patent 12077501 Compounds and compositions for intracellular delivery of agents
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11583504
Patent Primary Examiner
Shirley V Gembeh
CPC Code
A61K 9/0019
A61K 9/19
A61K 9/5123
Find more entities like US Patent 11583504 Stabilized formulations of lipid nanoparticles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE